Zhejiang Hisoar Pharmaceutical Co. Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Hisoar Pharmaceutical Co. Ltd with three other
companies in this sector in CHINA :
Dong-E-E-Jiao Co Ltd
sales of 2.96 billion Chinese Renmimbi [US$422.17 million]
of which 70%
was Pharmaceutical industry),
Gan & Lee Pharmaceuticals Co Ltd
(2.89 billion Chinese Renmimbi [US$412.30 million]
of which 97%
was Insulin and related products), and
Sihuan Pharmaceutical Holdings Group Ltd
(2.89 billion Chinese Renmimbi [US$411.31 million]
of which 100%
was Manufaturing and Sale of Pharmaceutical ).
Zhejiang Hisoar Pharmaceutical Co. Ltd reported sales of 2.94 billion Chinese Renmimbi (US$419.06 million)
December of 2019.
increase of 8.2%
versus 2018, when the company's sales were 2.72 billion Chinese Renmimbi.
Sales of Pharmatheutical Industry saw an increase
10.6% in 2019, from
1.45 billion Chinese Renmimbi to 1.60 billion Chinese Renmimbi.
Not all segments of Zhejiang Hisoar Pharmaceutical Co. Ltd experienced an increase in sales in 2019:
sales of Others fell 41.4% to 15.72 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).